| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 05/12/2010 | CN1612895B Conjugates comprising an antibody specific for the ED-B domain of fibronectin and their use for the detection and treatment of tumours |
| 05/12/2010 | CN101703786A Natural macromolecular ultrafine fibrous membrane marked with radioactive nuclide and preparation method thereof |
| 05/11/2010 | US7714103 Peptides, derivatives and analogs thereof, and methods of using same |
| 05/11/2010 | US7713936 Abuse-resistant amphetamine prodrugs |
| 05/11/2010 | US7713931 Cross-linked glycopeptide-cephalosporin antibiotics |
| 05/11/2010 | US7713552 Radiopaque implantable collagenous biomaterial device |
| 05/11/2010 | US7713528 Method for in vivo delivery of active compounds using reagent conjugate |
| 05/11/2010 | US7713517 Compositions and methods for enhancing contrast in imaging |
| 05/11/2010 | US7713514 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly |
| 05/11/2010 | CA2434512C Marker for inflammatory conditions |
| 05/11/2010 | CA2223261C Improved delivery of diagnostic and therapeutic agents to a target site |
| 05/11/2010 | CA2165297C Myeloid cell leukemia associated gene mcl-1 |
| 05/06/2010 | WO2010049819A1 Use of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h-pyridazino[4,5-b]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels |
| 05/06/2010 | WO2010048768A1 Nitroimidazole-amino acid compound type nuclide hypoxia imaging agent and intermediates for preparing them |
| 05/06/2010 | US20100113755 Isolated modified human chorionic gonadotropin proteins |
| 05/06/2010 | US20100112708 Methods and Mixtures Pertaining to Analyte Determination Using Electrophilic Labeling Reagents |
| 05/06/2010 | US20100111864 18f-labelled folates |
| 05/06/2010 | US20100111863 18f-labelled folates |
| 05/06/2010 | US20100111862 Radiolabelled inhibitors of the glycine 1 transporter |
| 05/06/2010 | US20100111861 Detection and quantification of abasic site formation in vivo |
| 05/06/2010 | US20100111860 Radioactive material containing chitosan for inhibiting cancer and preparation method thereof |
| 05/06/2010 | US20100111859 Visualization of Biological Material by the Use of Coated Contrast Agents |
| 05/06/2010 | US20100111858 Diangostic and Therapeutic Cyclooxygenase-2 Binding Ligands |
| 05/06/2010 | US20100111857 Compositions and methods for surface abrasion with frozen particles |
| 05/06/2010 | US20100111856 Zirconium-radiolabeled, cysteine engineered antibody conjugates |
| 05/06/2010 | US20100111855 Frozen compositions and methods for piercing a substrate |
| 05/06/2010 | US20100111854 Frozen compositions and methods for piercing a substrate |
| 05/06/2010 | US20100111853 Antibodies that bind to il-12 and methods of purifying the same |
| 05/06/2010 | US20100111852 Anti-Claudin 3 Monoclonal Antibody and Treatment and Diagnosis of Cancer Using the Same |
| 05/06/2010 | US20100111851 Diagnosis and treatment of cancer by using anti-prg-3 antibody |
| 05/06/2010 | US20100111850 Compositions and methods for administering compartmentalized frozen particles |
| 05/06/2010 | US20100111849 Compositions and methods for administering compartmentalized frozen particles |
| 05/06/2010 | US20100111848 Compositions and methods for administering compartmentalized frozen particles |
| 05/06/2010 | US20100111847 Compositions and methods for administering compartmentalized frozen particles |
| 05/06/2010 | US20100111846 Compositions and methods for delivery of frozen particle adhesives |
| 05/06/2010 | US20100111845 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111844 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111843 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111842 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111841 Compositions and methods for surface abrasion with frozen particles |
| 05/06/2010 | US20100111840 Stabilized therapeutic and imaging agents |
| 05/06/2010 | US20100111839 Selective inhibitors of translesion dna replication |
| 05/06/2010 | US20100111838 Brain-localizing polypeptides comprising a multivalent binding moiety and improved metabolic stability |
| 05/06/2010 | US20100111837 Compositions and methods for biological remodeling with frozen particle compositions |
| 05/06/2010 | US20100111836 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111835 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111834 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111833 Compositions and methods for surface abrasion with frozen particles |
| 05/06/2010 | US20100111832 Compositions and methods for surface abrasion with frozen particles |
| 05/06/2010 | US20100111831 Compositions and methods for surface abrasion with frozen particles |
| 05/06/2010 | US20100111830 Compositions and methods for surface abrasion with frozen particles |
| 05/06/2010 | US20100111829 Flowable composition that hardens on delivery to a target tissue site beneath the skin |
| 05/06/2010 | CA2741668A1 Novel substituted azabenzoxazoles |
| 05/06/2010 | CA2741620A1 Use of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h-pyridazino[4,5-b]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels |
| 05/05/2010 | EP2182004A1 Combination therapy of isotopically labelled chlorotoxin with temozolomide |
| 05/05/2010 | EP2181717A1 Use of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-B]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels |
| 05/05/2010 | EP2091453B1 A system, method, computer-readable medium, and use for planning combined therapy |
| 05/05/2010 | EP1411993B1 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 05/05/2010 | EP0888345B1 Sigma-2 receptors as biomarkers of tumor cell proliferation |
| 05/05/2010 | CN1950329B Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosi |
| 05/05/2010 | CN101700401A Polyalkylene glycol with moiety for conjugating biologicallyactive compound |
| 05/05/2010 | CN101056859B Quinoline derivatives as isotope labeling for adenosine a3 receptor ligand |
| 05/04/2010 | US7709613 administered as 188ReO4- or 186ReO4-; radiation dose is at least four-fold higher than that that could be delivered using the iodine radioisotope |
| 05/04/2010 | US7709031 Angiogenic agents from plant extracts, gallic acid, and derivatives |
| 05/04/2010 | CA2335364C Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 04/29/2010 | WO2010048144A2 Imaging and radiotherapy methods |
| 04/29/2010 | WO2010046796A1 Molecular imaging |
| 04/29/2010 | US20100104537 Methods of treating Parkinson's disease using viral vectors |
| 04/29/2010 | US20100104512 Dendritic Chelated Compounds, Methods for Making the Same and Pharmaceutical Compositions Containing the Same |
| 04/29/2010 | US20100104511 Methods and compositions using chelator-antibody conjugates |
| 04/29/2010 | US20100104510 Selenocysteine mediated hybrid antibody molecules |
| 04/29/2010 | US20100104509 Human antibodies that bind cd19 and uses thereof |
| 04/29/2010 | US20100104508 Human antibodies that bind cxcr4 and uses thereof |
| 04/29/2010 | US20100104507 Use of sterically stabilized cationic liposomes to efficiently deliver cpg oligonucleotides in vivo |
| 04/29/2010 | US20100104506 Nanoparticle-Coated Medical Devices And Formulations For Treating Vascular Disease |
| 04/29/2010 | US20100104505 System and Method for Quantitative Molecular Breast Imaging |
| 04/29/2010 | US20100104504 Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation |
| 04/29/2010 | US20100104503 Modular nanoparticles for adaptable vaccines |
| 04/29/2010 | US20100104502 Compositions and methods for detecting and treating endothelial dysfunction |
| 04/29/2010 | US20100104501 Prss23 as a biomarker, therapeutic and diagnostic target |
| 04/29/2010 | CA2738955A1 Imaging and radiotherapy methods |
| 04/28/2010 | EP2179926A1 Sterile, single-use device for preparing a radiopharmaceutical drug, system and method implementing this device |
| 04/28/2010 | EP2178920A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178919A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178918A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178817A1 A microsphere comprising an organic lanthanide metal complex |
| 04/28/2010 | EP1599228B1 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 04/28/2010 | CN1751041B 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 04/27/2010 | US7705049 Methods for treating non-melanoma cancers with PABA |
| 04/27/2010 | US7704956 Glutathione-based delivery system |
| 04/22/2010 | WO2010044744A1 Novel thiophene compounds for in vivo imaging |
| 04/22/2010 | WO2010043218A2 Tetrathiol ligands, metal complexes, conjugates, and kits, the use thereof in nuclear medicine diagnostics and endoradionuclide therapy, and method for producing the tetrathiol ligands and metal complexes |
| 04/22/2010 | WO2009151646A3 Non-invasive diagnostic agents and methods of diagnosing infectious disease |
| 04/22/2010 | WO2009027706A3 Radiolabeled monomeric and multimeric cyclic oligopeptides binding to the cxcr4 receptor for cancer imaging and treatment |
| 04/22/2010 | US20100098634 Imaging Agents Useful for Identifying AD Pathology |
| 04/22/2010 | US20100098633 Selective seprase inhibitors |
| 04/22/2010 | US20100098632 Hydroxyapatite particles |
| 04/22/2010 | US20100098631 Novel-2-Heteroaryl Substituted Indoles 695 |
| 04/22/2010 | US20100098630 Phenazine and Quinoxaline Substituted Amino Acids and Polypeptides |
| 04/22/2010 | US20100098629 Novel Amides Acting on the Adenosine Receptors |